The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

被引：0

作者：

Sharmin, Sifat ^{[1
,2
]}

Roos, Izanne ^{[1
,3
]}

Simpson-Yap, Steve ^{[1
,4
,5
]}

Malpas, Charles ^{[1
,3
]}

Lechner-Scott, Jeannette ^{[6
]}

Buzzard, Katherine ^{[7
]}

Skibina, Olga ^{[7
]}

van der Walt, Anneke ^{[8
]}

Butzkueven, Helmut ^{[8
]}

Kermode, Allan ^{[9
]}

Butler, Ernest ^{[10
]}

Barnett, Michael ^{[10
]}

Hodgkinson, Suzanne ^{[11
]}

McCombe, Pamela ^{[12
,13
,14
]}

Taylor, Bruce ^{[15
]}

Slee, Mark ^{[16
]}

Macdonell, Richard ^{[17
]}

Garber, Justin ^{[18
]}

Shaw, Cameron ^{[19
]}

Shuey, Neil ^{[20
]}

Massey, Jennifer ^{[21
]}

Hardy, Todd ^{[22
]}

Parratt, John ^{[23
]}

Kalincik, Tomas ^{[1
,3
]}

机构：

[1] Univ Melbourne, Dept Med, CORe, Melbourne, Australia

[2] Royal Melbourne Hosp, Dept Neurol, Neuroimmunol Ctr, Melbourne, Australia

[3] Royal Melbourne Hosp, Dept Neurol, Melbourne MS Ctr, Melbourne, Australia

[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Australia

[5] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia

[6] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, Australia

[7] Box Hill Hosp, Dept Neurol, Melbourne, Australia

[8] Alfred Hosp, Dept Neurol, Melbourne, Australia

[9] Univ Western Australia, Perron Inst, Nedlands, Australia

[10] Monash Med Ctr, Melbourne, Australia

[11] Brain & Mind Ctr, Sydney, NSW, Australia

[12] Liverpool Hosp, Sydney, Australia

[13] Univ Queensland, Brisbane, Australia

[14] Royal Brisbane & Womens Hosp, Brisbane, Australia

[15] Royal Hobart Hosp, Hobart, Australia

[16] Flinders Univ S Australia, Adelaide, SA, Australia

[17] Austin Hlth, Melbourne, Australia

[18] Westmead Hosp, Sydney, Australia

[19] Geelong Hosp, Geelong, Australia

[20] St Vincents Hosp, Fitzroy, Australia

[21] St Vincents Hosp Sydney, Sydney, Australia

[22] Concord Repatriat Gen Hosp, Sydney, Australia

[23] Royal North Shore Hosp, Sydney, Australia

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期

关键词：

secondary progressive multiple sclerosis; disease modifying therapy; latitude; geography; health expenditure;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：6 / 6

页数：1

共 50 条

[1] The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Sharmin, Sifat
Roos, Izanne
Simpson-Yap, Steve
Malpes, Charles
Sanchez, Marina M.
Ozakbas, Serkan
Horakova, Dana
Havrdova, Eva K.
Patti, Francesco
Alroughani, Raed
Izquierdo, Guillermo
Eichau, Sara
Boz, Cavit
Zakaria, Magd
Onofrj, Marco
Lugaresi, Alessandra
Weinstock-Guttman, Bianca
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Terzi, Murat
Amato, Maria Pia
Karabudak, Rana
Grand'Maison, Francois
Khoury, Samia J.
Grammond, Pierre
Lechner-Scott, Jeannette
Buzzard, Katherine
Skibina, Olga
van der Walt, Anneke
Butzkueven, Helmut
Turkoglu, Recai
Altintas, Ayse
Maimone, Davide
Kermode, Allan
Shalaby, Nevin
Pesch, Vincent V.
Butler, Ernest
Sidhom, Youssef
Gouider, Riadh
Mrabet, Saloua
Gerlach, Oliver
Soysal, Aysun
Barnett, Michael
Kuhle, Jens
Hughes, Stella
Sa, Maria J.
Hodgkinson, Suzanne
Oreja-Guevara, Celia
Ampapa, Radek
BRAIN, 2023, 146 (11) : 4633 - 4644
[2] The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Sharmin, S.
Roos, I.
Simpson-Yap, S.
Malpas, C.
Sanchez, M. Martinez
Ozakbas, S.
Horakova, D.
Havrdova, E. K.
Patti, F.
Alroughani, R.
Shaygannejad, V.
Izquierdo, G.
Eichau, S.
Boz, C.
Zakaria, M.
Onofrj, M.
Lugaresi, A.
Weinstock-Guttman, B.
Prat, A.
Girard, M.
Duquette, P.
Terzi, M.
Amato, M. P.
Karabudak, R.
Grand'Maison, F.
Yamout, B.
Khoury, S. J.
Grammond, P.
Lechner-Scott, J.
Buzzard, K.
Skibina, O.
Van der Walt, A.
Butzkueven, H.
Turkoglu, R.
Altintas, A.
Blanco, Y.
Maimone, D.
Kermode, A.
Shalaby, N.
Van Pesch, V.
Butler, E.
Sidhom, Y.
Gouider, R.
Gerlach, O.
Soysal, A.
Barnett, M.
Kuhle, J.
Hughes, S.
Sa, M. Jose
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 967 - 970
[3] Risk factors for secondary progressive multiple sclerosis
Gruszka, E.
Pokryszko-Dragan, A.
Dubik-Jezierzanska, M.
Bilinska, M.
MULTIPLE SCLEROSIS, 2006, 12 : S161 - S161
[4] Risk of secondary progressive multiple sclerosis: a longitudinal study
Fambiatos, A.
Jokubaitis, V.
Spelman, T.
Horakova, D.
Havrdova, E.
Trojano, M.
Prat, A.
Girard, M.
Duquette, P.
Lugaresi, A.
Izquierdo, G.
Grand'Maison, F.
Grammond, P.
Sola, P.
Ferraro, D.
Alroughani, R.
Terzi, M.
Hupperts, R.
Boz, C.
Lechner-Scott, J.
Pucci, E.
Bergamaschi, R.
Van Pesch, V.
Ozakbas, S.
Granella, F.
Ramo, C.
Turkoglu, R.
Iuliano, G.
Spitaleri, D.
McCombe, P.
Solaro, C.
Slee, M.
Fernandez-Bolanos, R.
Ampapa, R.
Soysal, A.
Petersen, T.
Sanchez-Menoyo, J. L.
Verheul, F.
Prevost, J.
Sidhom, Y.
Gouider, R.
Van Wijmeersch, B.
Vucic, S.
Cristiano, E.
Saladino, M. L.
Deri, N.
Barnett, M.
van der Walt, A.
Butzkueven, H.
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 109 - 112
[5] Risk of secondary progressive multiple sclerosis: A longitudinal study
Fambiatos, Adam
Jokubaitis, Vilija
Horakova, Dana
Havrdova, Eva Kubala
Trojano, Maria
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Lugaresi, Alessandra
Izquierdo, Guillermo
Grand'Maison, Francois
Grammond, Pierre
Sola, Patrizia
Ferraro, Diana
Alroughani, Raed
Terzi, Murat
Hupperts, Raymond
Boz, Cavit
Lechner-Scott, Jeannette
Pucci, Eugenio
Bergamaschi, Roberto
Van Pesch, Vincent
Ozakbas, Serkan
Granella, Franco
Turkoglu, Recai
Iuliano, Gerardo
Spitaleri, Daniele
McCombe, Pamela
Solaro, Claudio
Slee, Mark
Ampapa, Radek
Soysal, Aysun
Petersen, Thor
Sanchez-Menoyo, Jose Luis
Verheul, Freek
Prevost, Julie
Sidhom, Youssef
Van Wijmeersch, Bart
Vucic, Steve
Cristiano, Edgardo
Saladino, Maria Laura
Deri, Norma
Barnett, Michael
Olascoaga, Javier
Moore, Fraser
Skibina, Olga
Gray, Orla
Fragoso, Yara
Yamout, Bassem
Shaw, Cameron
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (01) : 79 - 90
[6] Risk of transition to secondary progressive multiple sclerosis and accumulation of disability in progressive multiple sclerosis are not influenced by current therapies
Alcala, C.
Gascon, F.
Perez-Miralles, F-C.
Escutia, M.
Coret, F.
Casanova, B.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 702 - 702
[7] Factors determining the risk of conversion to secondary progressive multiple sclerosis
Tedeholm, H.
Skoog, B.
Runmarker, B.
Oden, A.
Andersen, O.
MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 358 - 358
[8] Natalizumab in secondary progressive multiple sclerosis
Edan, Gilles
LANCET NEUROLOGY, 2018, 17 (05): : 384 - 385
[9] Siponimod in secondary progressive multiple sclerosis
Rissardo, Jamir Pitton
Caprara, Ana Leticia Fornari
INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2020, 7 (03) : 155 - 155
[10] Defining secondary progressive multiple sclerosis
Lorscheider, J.
Buzzard, K.
Jokubaitis, V.
Spelman, T.
Havrdova, E.
Horakova, D.
Trojano, M.
Izquierdo, G.
Girard, M.
Duquette, P.
Prat, A.
Lugaresi, A.
Grand'Maison, F.
Grammond, P.
Hupperts, R.
Alroughani, R.
Sola, P.
Boz, C.
Terzi, M.
Pucci, E.
Lechner-Scott, J.
Bergamaschi, R.
Oreja-Guevara, C.
Iuliano, G.
Van Pesch, V.
Bolanos, R. Fernandez
Granella, F.
Rio, M. E.
Ramo, C.
Spitaleri, D. L.
Petersen, T.
Slee, M.
Verheul, F.
Ampapa, R.
Amato, M. P.
McCombe, P.
Vucic, S.
Sanchez Menoyo, J. L.
Cristiano, E.
Barnett, M.
Hodgkinson, S.
Cabrera-Gomez, J. A.
Olascoaga, J.
Saladino, M. L.
Flechter, S.
Gray, O.
Deri, N.
Butzkueven, H.
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 798 - 800

← 1 2 3 4 5 →